seniors

Cognitive training shown to help healthy older adults

May, 2012

A comparison of multi-domain and single-domain cognitive training shows both improve cognitive performance in healthy older adults, but multi-domain training produces greater benefits.

Previous research has been equivocal about whether cognitive training helps cognitively healthy older adults. One recent review concluded that cognitive training could help slow age-related decline in a range of cognitive tasks; another found no evidence that such training helps slow or prevent the development of Alzheimer’s in healthy older adults. Most of the studies reviewed looked at single-domain training only: memory, reasoning, processing speed, reading, solving arithmetic problems, or strategy training (1). As we know from other studies, training in specific tasks is undeniably helpful for improving your performance at those specific tasks. However, there is little evidence for wider transfer. There have been few studies employing multi-domain training, although two such have found positive benefits.

In a new Chinese study, 270 healthy older adults (65-75) were randomly assigned to one of three groups. In the two experimental groups, participants were given one-hour training sessions twice a week for 12 weeks. Training took place in small groups of around 15. The first 15 minutes of each hour involved a lecture focusing on diseases common in older adults. The next 30 minutes were spent in instruction in one specific technique and how to use it in real life. The last 15 minutes were used to consolidate the skills by solving real-life problems.

One group were trained using a multi-domain approach, involving memory, reasoning, problem solving, map reading, handicrafts, health education and exercise. The other group trained on reasoning only (involving the towers of Hanoi, numerical reasoning, Raven Progressive Matrices, and verbal reasoning). Homework was assigned. Six months after training, three booster sessions (a month apart) were offered to 60% of the participants. The third group (the control) was put on a waiting list. All three groups attended a lecture on aspects of healthy living every two months.

All participants were given cognitive tests before training and after training, and again after 6 months, and after one year. Cognitive function was assessed using the Stroop Test, the Trail Making test, the Visual Reasoning test, and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS, Form A).

Both the multi-domain and single-domain cognitive training produced significant improvement in cognitive scores (the former in RBANS, visual reasoning, and immediate and delayed memory; the latter in RBANS, visual reasoning, word interference, and visuospatial/constructional score), although single-domain training produced less durable benefits (after a year, the multi-domain group still showed the benefit in RBANS, delayed memory and visual reasoning, while the single-domain group only showed benefits in word interference). Booster training also produced benefits, consolidating training in reasoning, visuospatial/constructional abilities and faster processing.

Reasoning ability seemed particularly responsive to training. Although it would be reasonable to assume that single-domain training, which focused on reasoning, would produce greater improvement than multi-domain training in this specific area, there was in fact no difference between the two groups right after training or at six months. And at 12 months, the multi-domain group was clearly superior.

In sum, the study provides evidence that cognitive training helps prevent cognitive decline in healthy older people, that specific training can generalize to other tasks, but that programs that involve several cognitive domains produce more lasting benefits.

Reference: 

Source: 

Topics: 

tags development: 

tags problems: 

tags strategies: 

Why exercise helps memory and learning

May, 2012

A mouse study suggests exercise increases neurogenesis through muscles’ release of an enzyme that affects energy and metabolism — an enzyme whose production lessens with age.

A number of studies, principally involving rodents, have established that physical exercise stimulates the creation of new brain cells in the hippocampus. A recent study attempted to uncover more about the mechanism.

Using two drugs that work directly on muscles, producing the physical effects of exercise, the researchers compared the effects on the brain. One drug (Aicar) improves the fitness of even sedentary animals. The other drug increases the effects of exercise on animals that exercise, but has little effect on sedentary animals.

After a week of receiving one of the drugs, sedentary mice performed better on tests of memory and learning, and showed more new brain cells. These effects were significantly greater for those taking Aicar.

Because the drugs have very little ability to cross into the brain, this demonstrates that the neurogenesis results from exercise-type reactions in the muscles, not to brain responses to the drugs. Indeed, previous research has found that direct infusion of Aicar into the brain impaired learning and memory.

Aicar increases the muscles’ output of AMPK, an enzyme that affects cellular energy and metabolism. It’s speculated that some of this enzyme may enter the bloodstream and travel to the brain. Interestingly, as with neurogenesis, AMPK activity in muscles appears to decline with age. It may be that AMPK production could serve as a biomarker for neurogenesis, as well as being a target for improving neurogenesis.

These findings add weight to evidence for the value of aerobic exercise over other types of exercise (given that the mice exercise by running). However, I see that human research has found that resistance training (which is difficult to study in mice!) also increases AMPK activity.

Do note — if you are hopeful that drugs will relieve you of the need to exercise — that the benefits were not only smaller than those achieved from exercise, but also didn’t last. In those mice taking Aicar for a second week, their brains not only stopped deriving any benefit, but actually deteriorated.

Reference: 

Source: 

Topics: 

tags development: 

tags lifestyle: 

tags problems: 

Resistance training benefits seniors with MCI

May, 2012

Six months of resistance training has improved executive function and associative memory in older women with mild cognitive impairment.

A study involving 86 older women (aged 70-80) with probable MCI has compared the effectiveness of resistance and aerobic training in improving executive function. The women were randomly allocated either to resistance training, aerobic training, or balance and tone training (control group). The programs all ran twice weekly for six months.

The 60-minute classes involved lifting weights (resistance training), outdoor walking (aerobic training), or stretching, balancing, and relaxation exercises (control).

Executive function was primarily assessed by the Stroop Test (measuring selective attention/conflict resolution), and also by Trail Making Tests (set-shifting) and Verbal Digits Tests (working memory). Associative memory (face-scene pairs) and problem-solving ability (Everyday Problems Test) were also assessed.

The study found that resistance training significantly improved performance on the Stroop Test and also the associative memory task. These improvements were associated with changes in some brain regions. In contrast to previous studies in healthy older adults, aerobic training didn’t produce any significant cognitive improvement, although it did produce significantly better balance and mobility, and cardiovascular capacity, compared to the control.

Interestingly, a previous study from these researchers demonstrated that it took a year of resistance training to achieve such results in cognitively healthy women aged 65-75. This suggests that the benefits may be greater for those at greater risk.

It may be that the greater benefits of resistance training over aerobic training are not be solely due to physical differences in the exercise. The researchers point out that resistance training required more cognitive engagement (“If you’re lifting weights you have to monitor your sets, your reps, you use weight machines and you have to adjust the seat, etc.”) compared to walking.

Note that impaired associative memory is one of the earliest cognitive functions affected in Alzheimer’s.

It’s also worth noting that exercise compliance was low (55-60%), suggesting that benefits might have been greater if the participants had been more motivated — or found the programs more enjoyable! The failure of aerobic exercise to improve cognition is somewhat surprising, and perhaps it, too, may be attributed to insufficient engagement — in terms of intensity as well as amount.

The researchers have put up a YouTube video of the resistance training exercises used in the study.

Reference: 

Source: 

Topics: 

tags development: 

tags lifestyle: 

tags problems: 

Being active reduces Alzheimer's risk

May, 2012
  • A large study provides evidence that higher levels of everyday activity help prevent Alzheimer’s, although more intense activity is even better.

A four-year study involving 716 elderly (average age 82) has revealed that those who were most physically active were significantly less likely to develop Alzheimer’s than those least active. The study is unique in that, in addition to self-reports of physical and social activity, activity was objectively measured (for up to 10 days) through a device worn on the wrist. This device (an actigraph) enabled everyday activity, such as cooking, washing the dishes, playing cards and even moving a wheelchair with a person's arms, to be included in the analysis.

Cognitive performance was assessed annually. Over the study period, 71 participants (10%) developed Alzheimer’s.

The study found that those in the bottom 10% of daily physical activity were more than twice as likely (2.3 times) to develop Alzheimer's disease as those in the top 10%. Those in the bottom 10% of intensity of physical activity were almost three times (2.8 times) as likely to develop Alzheimer's disease as people in the top 10%.

Moreover, the level of activity was associated with the rate of cognitive decline.

The association remained after motor function, depression, chronic health conditions, and APOE gene status were taken into account.

The findings should encourage anyone who feels that physical exercise is beyond them to nevertheless engage in milder forms of daily activity.

 

Addendum:

Another recent study, involving 331 cognitively healthy elderly, has also found that higher levels of physical activity were associated with better cognitive performance (specifically, a shorter time to complete the Trail-making test, and higher levels of verbal fluency) and less brain atrophy. Activity levels were based on the number of self-reported light and hard activities for at least 30 minutes per week. Participants were assessed in terms of MMSE score, verbal fluency, and visuospatial ability.

Reference: 

Source: 

Topics: 

tags development: 

tags lifestyle: 

tags problems: 

Berries protect the aging brain

May, 2012

A large, long-running study confirms that regular consumption of colorful berries helps protect against age-related cognitive decline.

Over the years, I have reported on several studies that have found evidence that colorful berries — blueberries in particular (but I think that’s more of an artifact, due to the relative cheapness of these berries in North America) — benefit older brains. Indeed, I myself consume these every day (in my lunch smoothie) for this very reason (of course, the fact that they taste so good doesn’t hurt!).

But to date these studies have involved rodents or only very small numbers of humans. Now a new study analyzes data from the very large and long-running Nurses' Health Study, which has questioned 121,700 female, registered nurses about their health and lifestyle since 1976. Since 1980, participants were also asked about their frequency of food consumption. Between 1995 and 2001, memory was measured in 16,010 participants over the age of 70 years (average age 74), at 2-year intervals.

The study found that those women who had 2 or more servings of strawberries and blueberries every week had a slower rate of cognitive decline. The effects were equivalent to some 1.5-2.5 years of normal cognitive aging.

While the researchers cannot completely rule out the possibility that higher berry consumption is associated with slower cognitive decline because of its association with some other factor that affects brain aging, they did take into account a large number of potentially confounding factors, including: education, smoking history and status, antidepressant use, BMI, blood pressure, cholesterol, diabetes, physical activity, total calorie intake, fish consumption, alcohol use, overall diet scores, and various indirect measures of socioeconomic status.

Moreover, the findings are both consistent with both animal and cell studies, and with what we know about how the brain ages. The ‘magic’ ingredient of these berries is thought to lie in their flavonoids (particularly anthocyanidins), which have powerful antioxidant and anti-inflammatory properties. It’s thought that berries help the brain stay healthy both because they contain high levels of antioxidants, which protect cells from damage by harmful free radicals, and because they change the way neurons in the brain communicate, protecting against inflammation and oxidative stress.

As a rule of thumb, the deeper the color of the berry (or other fruit or vegetable), the more flavonoids it has. You can see a list of anthocyanin-rich foods here (acai isn’t in the list, but it also has a very high rating).

Reference: 

Source: 

Topics: 

tags development: 

tags lifestyle: 

tags problems: 

Genes, brain size, brain atrophy, and Alzheimer’s risk

May, 2012

A round-up of genetic news.

  • Several genes are linked to smaller brain size and faster brain atrophy in middle- & old age.
  • The main Alzheimer's gene is implicated in leaky blood vessels, and shown to interact with brain size, white matter lesions, and dementia risk.
  • Some evidence suggests early-onset Alzheimer's is not so dissimilar to late-onset Alzheimer's.

Genetic analysis of 9,232 older adults (average age 67; range 56-84) has implicated four genes in how fast your hippocampus shrinks with age (rs7294919 at 12q24, rs17178006 at 12q14, rs6741949 at 2q24, rs7852872 at 9p33). The first of these (implicated in cell death) showed a particularly strong link to a reduced hippocampus volume — with average consequence being a hippocampus of the same size as that of a person 4-5 years older.

Faster atrophy in this crucial brain region would increase people’s risk of Alzheimer’s and cognitive decline, by reducing their cognitive reserve. Reduced hippocampal volume is also associated with schizophrenia, major depression, and some forms of epilepsy.

In addition to cell death, the genes linked to this faster atrophy are involved in oxidative stress, ubiquitination, diabetes, embryonic development and neuronal migration.

A younger cohort, of 7,794 normal and cognitively compromised people with an average age of 40, showed that these suspect gene variants were also linked to smaller hippocampus volume in this age group. A third cohort, comprised of 1,563 primarily older people, showed a significant association between the ASTN2 variant (linked to neuronal migration) and faster memory loss.

In another analysis, researchers looked at intracranial volume and brain volume in 8,175 elderly. While they found no genetic associations for brain volume (although there was one suggestive association), they did discover that intracranial volume (the space occupied by the fully developed brain within the skull — this remains unchanged with age, reflecting brain size at full maturity) was significantly associated with two gene variants (at loci rs4273712, on chromosome 6q22, and rs9915547, on 17q21). These associations were replicated in a different sample of 1,752 older adults. One of these genes is already known to play a unique evolutionary role in human development.

A meta-analysis of seven genome-wide association studies, involving 10,768 infants (average age 14.5 months), found two loci robustly associated with head circumference in infancy (rs7980687 on chromosome 12q24 and rs1042725 on chromosome 12q15). These loci have previously been associated with adult height, but these effects on infant head circumference were largely independent of height. A third variant (rs11655470 on chromosome 17q21 — note that this is the same chromosome implicated in the study of older adults) showed suggestive evidence of association with head circumference; this chromosome has also been implicated in Parkinson's disease and other neurodegenerative diseases.

Previous research has found an association between head size in infancy and later development of Alzheimer’s. It has been thought that this may have to do with cognitive reserve.

Interestingly, the analyses also revealed that a variant in a gene called HMGA2 (rs10784502 on 12q14.3) affected intelligence as well as brain size.

Why ‘Alzheimer’s gene’ increases Alzheimer’s risk

Investigation into the so-called ‘Alzheimer’s gene’ ApoE4 (those who carry two copies of this variant have roughly eight to 10 times the risk of getting Alzheimer’s disease) has found that ApoE4 causes an increase in cyclophilin A, which in turn causes a breakdown of the cells lining the blood vessels. Blood vessels become leaky, making it more likely that toxic substances will leak into the brain.

The study found that mice carrying the ApoE4 gene had five times as much cyclophilin A as normal, in cells crucial to maintaining the integrity of the blood-brain barrier. Blocking the action of cyclophilin A brought blood flow back to normal and reduced the leakage of toxic substances by 80%.

The finding is in keeping with the idea that vascular problems are at the heart of Alzheimer’s disease — although it should not be assumed from that, that other problems (such as amyloid-beta plaques and tau tangles) are not also important. However, one thing that does seem clear now is that there is not one single pathway to Alzheimer’s. This research suggests a possible treatment approach for those carrying this risky gene variant.

Note also that this gene variant is not only associated with Alzheimer’s risk, but also Down’s syndrome dementia, poor outcome following TBI, and age-related cognitive decline.

On which note, I’d like to point out recent findings from the long-running Nurses' Health Study, involving 16,514 older women (70-81), that suggest that effects of postmenopausal hormone therapy for cognition may depend on apolipoprotein E (APOE) status, with the fastest rate of decline being observed among HT users who carried the APOe4 variant (in general HT was associated with poorer cognitive performance).

It’s also interesting to note another recent finding: that intracranial volume modifies the effect of apoE4 and white matter lesions on dementia risk. The study, involving 104 demented and 135 nondemented 85-year-olds, found that smaller intracranial volume increased the risk of dementia, Alzheimer's disease, and vascular dementia in participants with white matter lesions. However, white matter lesions were not associated with increased dementia risk in those with the largest intracranial volume. But intracranial volume did not modify dementia risk in those with the apoE4 gene.

More genes involved in Alzheimer’s

More genome-wide association studies of Alzheimer's disease have now identified variants in BIN1, CLU, CR1 and PICALM genes that increase Alzheimer’s risk, although it is not yet known how these gene variants affect risk (the present study ruled out effects on the two biomarkers, amyloid-beta 42 and phosphorylated tau).

Same genes linked to early- and late-onset Alzheimer's

Traditionally, we’ve made a distinction between early-onset Alzheimer's disease, which is thought to be inherited, and the more common late-onset Alzheimer’s. New findings, however, suggest we should re-think that distinction. While the genetic case for early-onset might seem to be stronger, sporadic (non-familial) cases do occur, and familial cases occur with late-onset.

New DNA sequencing techniques applied to the APP (amyloid precursor protein) gene, and the PSEN1 and PSEN2 (presenilin) genes (the three genes linked to early-onset Alzheimer's) has found that rare variants in these genes are more common in families where four or more members were affected with late-onset Alzheimer’s, compared to normal individuals. Additionally, mutations in the MAPT (microtubule associated protein tau) gene and GRN (progranulin) gene (both linked to frontotemporal dementia) were also found in some Alzheimer's patients, suggesting they had been incorrectly diagnosed as having Alzheimer's disease when they instead had frontotemporal dementia.

Of the 439 patients in which at least four individuals per family had been diagnosed with Alzheimer's disease, rare variants in the 3 Alzheimer's-related genes were found in 60 (13.7%) of them. While not all of these variants are known to be pathogenic, the frequency of mutations in these genes is significantly higher than it is in the general population.

The researchers estimate that about 5% of those with late-onset Alzheimer's disease have changes in these genes. They suggest that, at least in some cases, the same causes may underlie both early- and late-onset disease. The difference being that those that develop it later have more protective factors.

Another gene identified in early-onset Alzheimer's

A study of the genes from 130 families suffering from early-onset Alzheimer's disease has found that 116 had mutations on genes already known to be involved (APP, PSEN1, PSEN2 — see below for some older reports on these genes), while five of the other 14 families all showed mutations on a new gene: SORL1.

I say ‘new gene’ because it hasn’t been implicated in early-onset Alzheimer’s before. However, it has been implicated in the more common late-onset Alzheimer’s, and last year a study reported that the gene was associated with differences in hippocampal volume in young, healthy adults.

The finding, then, provides more support for the idea that some cases of early-onset and late-onset Alzheimer’s have the same causes.

The SORL1 gene codes for a protein involved in the production of the beta-amyloid peptide, and the mutations seen in this study appear to cause an under-expression of SORL1, resulting in an increase in the production of the beta-amyloid peptide. Such mutations were not found in the 1500 ethnicity-matched controls.

 

Older news reports on these other early-onset genes (brought over from the old website):

New genetic cause of Alzheimer's disease

Amyloid protein originates when it is cut by enzymes from a larger precursor protein. In very rare cases, mutations appear in the amyloid precursor protein (APP), causing it to change shape and be cut differently. The amyloid protein that is formed now has different characteristics, causing it to begin to stick together and precipitate as amyloid plaques. A genetic study of Alzheimer's patients younger than 70 has found genetic variations in the promoter that increases the gene expression and thus the formation of the amyloid precursor protein. The higher the expression (up to 150% as in Down syndrome), the younger the patient (starting between 50 and 60 years of age). Thus, the amount of amyloid precursor protein is a genetic risk factor for Alzheimer's disease.

Theuns, J. et al. 2006. Promoter Mutations That Increase Amyloid Precursor-Protein Expression Are Associated with Alzheimer Disease. American Journal of Human Genetics, 78, 936-946.

http://www.eurekalert.org/pub_releases/2006-04/vfii-rda041906.php

Evidence that Alzheimer's protein switches on genes

Amyloid b-protein precursor (APP) is snipped apart by enzymes to produce three protein fragments. Two fragments remain outside the cell and one stays inside. When APP is produced in excessive quantities, one of the cleaved segments that remains outside the cell, called the amyloid b-peptides, clumps together to form amyloid plaques that kill brain cells and may lead to the development of Alzheimer’s disease. New research indicates that the short "tail" segment of APP that is trapped inside the cell might also contribute to Alzheimer’s disease, through a process called transcriptional activation - switching on genes within the cell. Researchers speculate that creation of amyloid plaque is a byproduct of a misregulation in normal APP processing.

[2866] Cao, X., & Südhof T. C.
(2001).  A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60.
Science. 293(5527), 115 - 120.

http://www.eurekalert.org/pub_releases/2001-07/aaft-eta070201.php

Inactivation of Alzheimer's genes in mice causes dementia and brain degeneration

Mutations in two related genes known as presenilins are the major cause of early onset, inherited forms of Alzheimer's disease, but how these mutations cause the disease has not been clear. Since presenilins are involved in the production of amyloid peptides (the major components of amyloid plaques), it was thought that such mutations might cause Alzheimer’s by increasing brain levels of amyloid peptides. Accordingly, much effort has gone into identifying compounds that could block presenilin function. Now, however, genetic engineering in mice has revealed that deletion of these genes causes memory loss and gradual death of nerve cells in the mouse brain, demonstrating that the protein products of these genes are essential for normal learning, memory and nerve cell survival.

Saura, C.A., Choi, S-Y., Beglopoulos, V., Malkani, S., Zhang, D., Shankaranarayana Rao, B.S., Chattarji, S., Kelleher, R.J.III, Kandel, E.R., Duff, K., Kirkwood, A. & Shen, J. 2004. Loss of Presenilin Function Causes Impairments of Memory and Synaptic Plasticity Followed by Age-Dependent Neurodegeneration. Neuron, 42 (1), 23-36.

http://www.eurekalert.org/pub_releases/2004-04/cp-ioa032904.php

Reference: 

[2858] Consortium, E N I G M-A(ENIGMA)., & Cohorts Heart Aging Research Genomic Epidemiology(charge)
(2012).  Common variants at 12q14 and 12q24 are associated with hippocampal volume.
Nature Genetics. 44(5), 545 - 551.

[2909] Taal, R. H., Pourcain B S., Thiering E., Das S., Mook-Kanamori D. O., Warrington N. M., et al.
(2012).  Common variants at 12q15 and 12q24 are associated with infant head circumference.
Nature Genetics. 44(5), 532 - 538.

[2859] Cohorts Heart Aging Research Genomic Epidemiology,(charge), & Consortium E G G(EGG).
(2012).  Common variants at 6q22 and 17q21 are associated with intracranial volume.
Nature Genetics. 44(5), 539 - 544.

[2907] Stein, J. L., Medland S. E., Vasquez A A., Hibar D. P., Senstad R. E., Winkler A. M., et al.
(2012).  Identification of common variants associated with human hippocampal and intracranial volumes.
Nature Genetics. 44(5), 552 - 561.

[2925] Bell, R. D., Winkler E. A., Singh I., Sagare A. P., Deane R., Wu Z., et al.
(2012).  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.
Nature.

Kang, J. H., & Grodstein F. (2012).  Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline. Neurobiology of Aging. 33(7), 1129 - 1137.

Skoog, I., Olesen P. J., Blennow K., Palmertz B., Johnson S. C., & Bigler E. D. (2012).  Head size may modify the impact of white matter lesions on dementia. Neurobiology of Aging. 33(7), 1186 - 1193.

[2728] Cruchaga, C., Chakraverty S., Mayo K., Vallania F. L. M., Mitra R. D., Faber K., et al.
(2012).  Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families.
PLoS ONE. 7(2), e31039 - e31039.

Full text available at http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0031039

[2897] Pottier, C., Hannequin D., Coutant S., Rovelet-Lecrux A., Wallon D., Rousseau S., et al.
(2012).  High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease.
Molecular Psychiatry.

McCarthy, J. J., Saith S., Linnertz C., Burke J. R., Hulette C. M., Welsh-Bohmer K. A., et al. (2012).  The Alzheimer's associated 5′ region of the SORL1 gene cis regulates SORL1 transcripts expression. Neurobiology of Aging. 33(7), 1485.e1-1485.e8 - 1485.e1-1485.e8

Source: 

Topics: 

tags: 

tags development: 

tags memworks: 

tags problems: 

Video game training benefits cognition in some older adults

April, 2012

A study has found that playing a cognitively complex video game improved cognitive performance in some older adults, particularly those with initially poorer cognitive scores.

A number of studies have found evidence that older adults can benefit from cognitive training. However, neural plasticity is thought to decline with age, and because of this, it’s thought that the younger-old, and/or the higher-functioning, may benefit more than the older-old, or the lower-functioning. On the other hand, because their performance may already be as good as it can be, higher-functioning seniors may be less likely to benefit. You can find evidence for both of these views.

In a new study, 19 of 39 older adults (aged 60-77) were given training in a multiplayer online video game called World of Warcraft (the other 20 formed a control group). This game was chosen because it involves multitasking and switching between various cognitive abilities. It was theorized that the demands of the game would improve both spatial orientation and attentional control, and that the multiple tasks might produce more improvement in those with lower initial ability compared to those with higher ability.

WoW participants were given a 2-hour training session, involving a 1-hour lecture and demonstration, and one hour of practice. They were then expected to play the game at home for around 14 hours over the next two weeks. There was no intervention for the control group. All participants were given several cognitive tests at the beginning and end of the two week period: Mental Rotation Test; Stroop Test; Object Perspective Test; Progressive Matrices; Shipley Vocabulary Test; Everyday Cognition Battery; Digit Symbol Substitution Test.

As a group, the WoW group improved significantly more on the Stroop test (a measure of attentional control) compared to the control group. There was no change in the other tests. However, those in the WoW group who had performed more poorly on the Object Perspective Test (measuring spatial orientation) improved significantly. Similarly, on the Mental Rotation Test, ECB, and Progressive Matrices, those who performed more poorly at the beginning tended to improve after two weeks of training. There was no change on the Digit Symbol test.

The finding that only those whose performance was initially poor benefited from cognitive training is consistent with other studies suggesting that training only benefits those who are operating below par. This is not really surprising, but there are a few points that should be made.

First of all, it should be noted that this was a group of relatively high-functioning young-old adults — poorer performance in this case could be (relatively) better performance in another context. What it comes down to is whether you are operating at a level below which you are capable of — and this applies broadly, for example, experiments show that spatial training benefits females but not males (because males tend to already have practiced enough).

Given that, in expertise research, training has an on-going, apparently limitless, effect on performance, it seems likely that the limited benefits shown in this and other studies is because of the extremely limited scope of the training. Fourteen hours is not enough to improve people who are already performing adequately — but that doesn’t mean that they wouldn’t improve with more hours. I have yet to see any interventions with older adults that give them the amount of cognitive training you would expect them to need to achieve some level of mastery.

My third and final point is the specific nature of the improvements. This has also been shown in other studies, and sometimes appears quite arbitrary — for example, one 3-D puzzle game apparently improved mental rotation, while a different 3-D puzzle game had no effect. The point being that we still don’t understand the precise attributes needed to improve different skills (although the researchers advocate the use of a tool called cognitive task analysis for revealing the underlying qualities of an activity) — but we do understand that it is a matter of precise attributes, which is definitely a step in the right direction.

The main thing, then, that you should take away from this is the idea that different activities involve specific cognitive tasks, and these, and only these, will be the ones that benefit from practicing the activities. You therefore need to think about what tasks you want to improve before deciding on the activities to practice.

Reference: 

Source: 

Topics: 

tags development: 

tags lifestyle: 

tags memworks: 

tags problems: 

tags strategies: 

Hypertension & Cognition

Older news items (pre-2010) brought over from the old website

High blood pressure linked to memory problems in middle age

A study involving nearly 20,000 people age 45 and older, of whom nearly half were taking medication for high blood pressure, has found that those with high diastolic blood pressure (the bottom number of a blood pressure reading) were more likely to have cognitive impairment than those with normal diastolic readings. For every 10 point increase in the reading, the odds of a person having cognitive problems was 7% higher. There was no correlation with systolic blood pressure. The results were adjusted for age, smoking status, exercise level, education, diabetes and high cholesterol. High diastolic blood pressure is known to lead to weakening of small arteries in the brain.

[750] Tsivgoulis, G., Alexandrov A. V., Wadley V. G., Unverzagt F. W., Go R. C. P., Moy C. S., et al.
(2009).  Association of higher diastolic blood pressure levels with cognitive impairment.
Neurology. 73(8), 589 - 595.

http://www.eurekalert.org/pub_releases/2009-08/aaon-hbp081809.php

A diet that may reduce age-related cognitive decline

The Dietary Approaches to Stop Hypertension (DASH) diet lowers blood pressure and is often recommended by physicians to people with high blood pressure or pre-hypertension. An 11-year study of over 3800 seniors found that those with higher DASH diet adherence scores had higher cognitive scores at the beginning of the study and increasingly so over time. Four of the nine food-group/nutrient components were independently associated with cognitive scores -- vegetables, whole grains, low-fat dairy, nut/legumes. When a score based on just these four components was used, the difference between those in the highest quintile and those in the lowest was even greater, particularly by the end of the study.

Wengreen, H.J. et al. 2009. DASH diet adherence scores and cognitive decline and dementia among aging men and women: Cache County study of Memory Health and Aging. Presented at the Alzheimer's Association International Conference on Alzheimer's Disease July 11-16 in Vienna.

Factors helping you maintain cognitive function in old age

An 8-year study of over 2,500 seniors in their 70s, has found that 53% showed normal age-related decline, 16% showed major cognitive decline, and an encouraging 30% had no change or improved on the tests over the years. The most important factors in determining whether a person maintained their cognitive health was education and literacy: those with a ninth grade literacy level or higher were nearly five times as likely to stay sharp than those with lower literacy levels; those with at least a high school education were nearly three times as likely to stay sharp as those who have less education. Lifestyle factors were also significant: non-smokers were nearly twice as likely to stay sharp as smokers; those who exercised moderately to vigorously at least once a week were 30% more likely to maintain their cognitive function than those who do not exercise that often; people working or volunteering and people who report living with someone were 24% more likely to maintain cognitive function.

[909] Ayonayon, H. N., Harris T. B., For the Health ABC Study, Yaffe K., Fiocco A. J., Lindquist K., et al.
(2009).  Predictors of maintaining cognitive function in older adults: The Health ABC Study.
Neurology. 72(23), 2029 - 2035.

http://www.eurekalert.org/pub_releases/2009-06/aaon-ssn060209.php

Hypertension in children linked to cognitive problems

A study of 32 newly diagnosed hypertensive children and adolescents (10 to 18 years old) plus 32 matched children with normal blood pressure has revealed that, according to parental assessment, those with high blood pressure scored significantly lower on executive function — that is, were poorer at planning, at complicated goal-directed tasks, and had more working memory problems. Additionally, more than half the children with both hypertension and obesity demonstrated clinically significant anxiety and depression.

Lande, M.B. et al. 2009. Parental Assessments of Internalizing and Externalizing Behavior and Executive Function in Children with Primary Hypertension. Journal of Pediatrics, 154 (2), 207-212.

http://www.eurekalert.org/pub_releases/2009-02/uorm-cwh022409.php

High blood pressure may make it difficult for the elderly to think clearly

A study involving 36 community-dwelling elderly (60-87 years old) whose blood pressure and cognitive functioning was monitored for 60 days has found that those with high blood pressure tended to perform more poorly on one of the three cognitive tasks, and this was particularly so when their blood pressure was higher than normal. The finding suggests that high blood pressure impacts on inductive reasoning, and thus the ability to work flexibly with unfamiliar information and find solutions. It also suggests that, for those with high blood pressure, such reasoning will be particularly difficult when they are stressed.

Gamaldo, A.A., Weatherbee, S.R. & Allaire, J.C. 2008. Exploring the Within-Person Coupling of Blood Pressure and Cognition in Elders. Journal of Gerontology: Psychological Science, 63, 386-389.

http://www.eurekalert.org/pub_releases/2008-12/ncsu-hbp121008.php

High blood pressure associated with risk for mild cognitive impairment

A study of nearly 1000 older adults (average age 76.3) without mild cognitive impairment at the start of the study found that over the follow-up period (average: 4.7 years), 334 individuals developed mild cognitive impairment, of which 160 were amnestic (reduced memory) and 174 were non-amnestic. Hypertension (high blood pressure) was associated with an increased risk of non-amnestic mild cognitive impairment; but not with amnestic mild cognitive impairment.

[712] Reitz, C., Tang M-X., Manly J., Mayeux R., & Luchsinger J. A.
(2007).  Hypertension and the Risk of Mild Cognitive Impairment.
Arch Neurol. 64(12), 1734 - 1740.

http://www.eurekalert.org/pub_releases/2007-12/jaaj-hbp120607.php

Memory tasks require more coordinated brain blood flow for people with high blood pressure

Previous studies have found an association between high blood pressure and cognitive decline in older adults, but the evidence hasn’t been entirely consistent. Now a new study helps explain why the situation is not entirely straightforward. It appears that people with high blood pressure required more blood flow to the parts of the brain that support memory function than those with normal blood pressure. Moreover, and surprisingly, it turned out that antihypertensive medication actually made it worse, increasing the inefficiency of the brain’s work during memory tasks.

The findings were reported at the American Heart Association’s 61st Annual Fall Conference of the Council for High Blood Pressure Research.

http://www.eurekalert.org/pub_releases/2007-09/aha-mtr092707.php

Lowering blood pressure doesn't prevent cognitive impairment, dementia

A review of three large-scale studies of patients with hypertension who were treated with either medication or lifestyle strategies found no convincing evidence that lowering blood pressure prevents the development of dementia or cognitive impairment in hypertensive patients without apparent prior cerebrovascular disease. However, there is some evidence that midlife hypertension but not late life hypertension is related to cognitive decline; these studies involved patients aged 60 and older.

McGuiness, B., et al. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. The Cochrane Database of Systematic Reviews 2006, Issue 2.

http://www.eurekalert.org/pub_releases/2006-05/cfta-lbp052306.php

Review supports link between lifestyle factors and cognitive function in older adults

A review of 96 papers involving 36 very large, ongoing epidemiological studies in North America and Europe looking at factors involved in maintaining cognitive and emotional health in adults as they age has concluded that controlling cardiovascular risk factors, such as reducing blood pressure, reducing weight, reducing cholesterol, treating (or preferably avoiding) diabetes, and not smoking, is important for maintaining brain health as we age. The link between hypertension and cognitive decline was the most robust across studies. They also found a consistent close correlation between physical activity and brain health. However, they caution that more research is needed before specific recommendations can be made about which types of exercise and how much exercise are beneficial. They also found protective factors most consistently reported for cognitive health included higher education level, higher socio-economic status, emotional support, better initial performance on cognitive tests, better lung capacity, more physical exercise, moderate alcohol use, and use of vitamin supplements. Psychosocial factors, such as social disengagement and depressed mood, are associated with both poorer cognitive and emotional health in late life. Increased mental activity throughout life, such as learning new things, may also benefit brain health.

[296] Wagster, M., Hendrie H., Albert M., Butters M., Gao S., Knopman D. S., et al.
(2006).  The NIH Cognitive and Emotional Health ProjectReport of the Critical Evaluation Study Committee.
Alzheimer's and Dementia. 2(1), 12 - 32.

http://www.eurekalert.org/pub_releases/2006-02/aa-nss021606.php

Uncontrolled high blood pressure means more cognitive problems in old age

A study involving a subset of men (average age 67 years) in the VA Normative Aging Study has found that those men with uncontrolled hypertension performed significantly worse on tests of verbal fluency and short-term memory. Those whose hypertension was controlled did as well as those with normal blood pressure. In the United States, hypertension affects 60% of adults age 60 and older, and a high proportion of these are untreated or inadequately treated.

Brady, C.B., Spiro, A. III & Gaziano, J.M. 2005. Effects of Age and Hypertension Status on Cognition: The Veterans Affairs Normative Aging Study. Neuropsychology, 19 (6).

http://www.eurekalert.org/pub_releases/2005-12/apa-uhb113005.php

High blood pressure has stronger effect on cognitive function in African-Americans

Analysis of a large longitudinal study (the Maine-Syracuse Longitudinal Study 1976—2002) has found significant associations of high blood pressure to lower cognitive performance in the areas of abstract reasoning, psychomotor skills and visual organization skills. This association, moreover, was significantly greater for African-Americans, although it should be noted that there were only 147 African-Americans among the 1,563 participants. The effect was independent of age.

[795] Robbins, M. A., Elias M. F., Elias P. K., & Budge M. M.
(2005).  Blood pressure and cognitive function in an African-American and a Caucasian-American sample: the Maine-Syracuse Study.
Psychosomatic Medicine. 67(5), 707 - 714.

http://www.eurekalert.org/pub_releases/2005-09/cfta-hbp092205.php

High blood pressure may be a factor in "senior moments"

An imaging study of seniors (average age 60) found that those with high blood pressure showed reduced blood flow to active brain areas when performing various everyday memory tasks, such as looking up a phone number then walking to another room to pick up the phone and dial the number. The diminished blood flow correlated to slightly worse scores on the memory tests. The differences weren’t large, but may help account for "senior moments" - memory problems commonly associated with age. It’s estimated that as many as a third of those with high blood pressure are not aware they have it.

Jennings, J.R., Muldoon, M.F., Meltzer, C.C., Ryan, C. & Price, J. 2003. Human Cerebral Blood Flow Responses to Information Processing Tasks are Decreased in Hypertensives Relative to Normotensives. Report presented at the American Heart Association's 57th Annual High Blood Pressure Research Conference, September 23.

http://www.eurekalert.org/pub_releases/2003-09/aha-hbp091703.php

Effects of high blood pressure on cognition may have been overstated

Epidemiological studies have suggested hypertensive patients perform worse than individuals with normal blood pressure on cognition tests. A new study has investigated performance on specific cognitive tasks (visual and memory search involving computer displays) by those with high blood pressure who were not on medication and had no detectable cardiovascular disease. Participants ranged in age from 20 to 80. Contrary to expectation, high blood pressure slowed performance only in the middle-aged group (40-59), not in those younger or older.

Madden, D., Langley, L., Thurston, R., Whiting, W. & Blumenthal, J. 2003. Interaction of Blood Pressure and Adult Age in Memory Search and Visual Search Performance. Aging, Neuropsychology and Cognition, 10 (4), 241-54.

http://www.eurekalert.org/pub_releases/2003-09/dumc-hbp092503.php

Treatment to lower blood pressure reduces risk of cognitive decline in stroke patients

High blood pressure and stroke are associated with increased risks of dementia and cognitive impairment. In a study aimed to determine whether blood pressure lowering would reduce the risks of dementia and cognitive decline among individuals with cerebrovascular disease, 6105 people with prior stroke or transient ischemic attack were given either active treatment (perindopril for all participants and indapamide for those with neither an indication for nor a contraindication to a diuretic) or matching placebo(s). Over some 4 years, dementia was found in 6.3% of those given active treatment and 7.1% of those in the placebo group. Cognitive decline occurred in 9.1% of the actively treated group and 11.0% of the placebo group. The researchers concluded that blood pressure lowering with perindopril and indapamide therapy was helpful for those with cerebrovascular disease, in terms of reduced risks of dementia and cognitive decline.

[603] The PROGRESS Collaborative Group*
(2003).  Effects of Blood Pressure Lowering With Perindopril and Indapamide Therapy on Dementia and Cognitive Decline in Patients With Cerebrovascular Disease.
Arch Intern Med. 163(9), 1069 - 1075.

http://archinte.ama-assn.org/cgi/content/abstract/163/9/1069

Age-related changes in the brain's white matter affect cognitive function

From around age 60, "white-matter lesions" appear in the brain, significantly affecting cognitive function. But without cognitive data from childhood, it is hard to know how much of the difference in cognitive abilities between elderly individuals is due to aging. A longitudinal study has been made possible by the Scottish Mental Survey of 1932, which gave 11-year-olds a validated cognitive test. Scottish researchers have tracked down healthy living men and women who took part in this Survey and retested 83 participants. Testing took place in 1999, when most participants were 78 years old.
It was found that the amount of white-matter lesions made a significant contribution to general cognitive ability differences in old age, independent of prior ability. The amount of white-matter lesions contributed 14.4% of the variance in cognitive scores; early IQ scores contributed 13.7%. The two factors were independent.
Although white-matter lesions are viewed as a normal part of aging, they are linked with other health problems, in particular to circulatory problems (including hypertension, diabetes, heart disease and cardiovascular risk factors).

[442] Deary, I. J., Leaper S. A., Murray A. D., Staff R. T., & Whalley L. J.
(2003).  Cerebral white matter abnormalities and lifetime cognitive change: a 67-year follow-up of the Scottish Mental Survey of 1932.
Psychology and Aging. 18(1), 140 - 148.

http://www.eurekalert.org/pub_releases/2003-03/apa-aci031703.php

Sunflower seeds helpful in reducing hypertension and associated cognitive impairment

Research in rats has found that linoleic acid improved not only blood pressure, but also hypertension-induced memory decline, suggesting that the early incorporation of linoleic acid in the diet, may not only help in controlling hypertension, but may also improve hypertension-induced cognitive impairment. Linoleic acid is found in vegetable seed oils, such as safflower, sunflower, and hemp seed.

Holloway, V. 2002. Effects of early nutritional supplementation of linoleic acid in Hypertension. Paper presented at an American Physiological Society (APS) conference, "The Power of Comparative Physiology: Evolution, Integration and Application", August 24-28 in San Diego, CA.

http://www.eurekalert.org/pub_releases/2002-08/aps-mk082602.php

High blood pressure increases risk of cognitive decline in older adults

A large-scale six-year study of people aged 40 to 70 years old found that people with diabetes and high blood pressure are more likely to experience cognitive decline. Diabetes was associated with greater cognitive decline for those younger than 58 as well as those older than 58, but high blood pressure was a risk factor only for the 58 and older group.

[2534] Knopman, D. S., Boland L. L., Mosley T., Howard G., Liao D., Szklo M., et al.
(2001).  Cardiovascular risk factors and cognitive decline in middle-aged adults.
Neurology. 56(1), 42 - 48.

http://www.eurekalert.org/pub_releases/2001-01/MC-Nsld-0701101.php
http://www.eurekalert.org/pub_releases/2001-01/AAoN-Dahb-0801101.php

Untreated hypertension linked to severe cognitive decline in older adults

A large-scale study of French people aged 59 to 71 found that, after four years, 21.7% of those with untreated high blood pressure experienced severe cognitive decline. Of those with high blood pressure whose treatment didn't bring the blood pressure down to normal, 12.5% had severe cognitive decline. Of those whose high blood pressure was successfully treated, 7.8% had severe cognitive decline. Only 7.3% of those with normal blood pressure had severe cognitive decline.

Tzourio, C., Dufouil, C., Ducimetière, P., Alpérovitch, A. and for the EVA Study Group. 1999. Cognitive decline in individuals with high blood pressure: A longitudinal study in the elderly. Neurology, 53, 1948.

http://www.eurekalert.org/pub_releases/1999-12/AAoN-Hbpi-091299.php

tags development: 

tags problems: 

Fluctuating sense of control linked to cognitive ability in older adults

April, 2012

A small study has found that, in older adults, their sense of control fluctuates over the course of a day, and this affects their cognitive abilities.

Previous research has pointed to a typical decline in our sense of control as we get older. Maintaining a sense of control, however, appears to be a key factor in successful aging. Unsurprisingly, in view of the evidence that self-belief and metacognitive understanding are important for cognitive performance, a stronger sense of control is associated with better cognitive performance. (By metacognitive understanding I mean the knowledge that cognitive performance is malleable, not fixed, and strategies and training are effective in improving cognition.)

In an intriguing new study, 36 older adults (aged 61-87, average age 74) had their cognitive performance and their sense of control assessed every 12 hours for 60 days. Participants were asked questions about whether they felt in control of their lives and whether they felt able to achieve goals they set for themselves.

The reason I say this is intriguing is that it’s generally assumed that a person’s sense of control — how much they feel in control of their lives — is reasonably stable. While, as I said, it can change over the course of a lifetime, until recently we didn’t think that it could fluctuate significantly in the course of a single day — which is what this study found.

Moreover, those who normally reported having a low sense of control performed much better on inductive reasoning tests during periods when they reported feeling a higher sense of control. Similarly, those who normally reported feeling a high sense of control scored higher on memory tests when feeling more in control than usual.

Although we can’t be sure (since this wasn’t directly investigated), the analysis suggests that the improved cognitive functioning stems from the feeling of improved control, not vice versa.

The study builds on an earlier study that found weekly variability in older adults’ locus of control and competency beliefs.

Assessment was carried out in the form of a daily workbook, containing a number of measures, which participants completed twice daily. Each assessment took around 30-45 minutes to complete. The measures included three cognitive tests (14 alternate forms of each of these were used, to minimize test familiarity):

  • Letter series test: 30 items in which the next letter in a series had to be identified. [Inductive reasoning]
  • Number comparison: 48 items in which two number strings were presented beside each other, and participants had to identify where there was any mismatch. [Perceptual speed]
  • Rey Auditory Verbal Learning Task: participants have to study a list of 15 unrelated words for one minute, then on another page recall as many of the words as they could. [Memory]

Sense of control over the previous 12 hours was assessed by 8 questions, to which participants indicated their agreement/disagreement on a 6-point scale. Half the questions related to ‘locus of control’ and half to ‘perceived competence’.

While, unsurprisingly, compliance wasn’t perfect (it’s quite an arduous regime), participants completed on average 115 of 120 workbooks. Of the possible 4,320 results (36 x 120), only 166 were missing.

One of the things that often annoys me is the subsuming of all within-individual variability in cognitive scores into averages. Of course averages are vital, but so is variability, and this too often is glossed over. This study is, of course, all about variability, so I was very pleased to see people’s cognitive variability spelled out.

Most of the variance in locus of control was of course between people (86%), but 14% was within-individual. Similarly, the figures for perceived competence were 88% and 12%. (While locus of control and perceived competence are related, only 26% of the variability in within-person locus of control was associated with competence, meaning that they are largely independent.)

By comparison, within-individual variability was much greater for the cognitive measures: for the letter series (inductive reasoning), 32% was within-individual and 68% between-individual; for the number matching (perceptual speed), 21% was within-individual and 79% between-individual; for the memory test, an astounding 44% was within-individual and 56% between-individual.

Some of this within-individual variability in cognitive performance comes down to practice effects, which were significant for all cognitive measures. For the memory test, time of day was also significant, with performance being better in the morning. For the letter and number series tests, previous performance also had a small effect on perceived competence. For the number matching, increase in competence subsequent to increased performance was greatest for those with lower scores. However, lagged analyses indicated that beliefs preceded performance to a greater extent than performance preceding beliefs.

While it wasn’t an aspect of this study, it should also be noted that a person’s sense of control may well vary according to domain (e.g., cognition, social interaction, health) and context. In this regard, it’s interesting to note the present findings that sense of control affected inductive reasoning for low-control individuals, but memory for high-control individuals, suggesting that the cognitive domain also matters.

Now this small study was a preliminary one and there are several limitations that need to be tightened up in subsequent research, but I think it’s important for three reasons:

  • as a demonstration that cognitive performance is not a fixed attribute;
  • as a demonstration of the various factors that can affect older adults’ cognitive performance;
  • as a demonstration that your beliefs about yourself are a factor in your cognitive performance.

Reference: 

[2794] Neupert, S. D., & Allaire J. C.
(2012).  I think I can, I think I can: Examining the within-person coupling of control beliefs and cognition in older adults.
Psychology and Aging. No Pagination Specified - No Pagination Specified.

Source: 

Topics: 

tags development: 

tags memworks: 

tags problems: 

tags strategies: 

Larger belly linked to memory problems in people with HIV

April, 2012

HIV-related cognitive impairment is significantly associated with a greater waist circumference, and in older adults, with diabetes.

A study involving 130 HIV-positive people has found that memory impairment was associated with a significantly larger waistline.

Some 40% of participants (average age 46) had impaired cognition. This group had an average waist circumference of 39 inches, compared to 35 inches for those without such problems. Memory impairment was also linked to diabetes in those older than 55 (15% of those with memory problems had diabetes compared to only 3% of those without memory problems).

Waistline was more important than BMI. Unfortunately, some anti-HIV drugs cause weight gain in this area.

The finding is consistent with evidence that abdominal weight is more important than overall weight for cognitive impairment and dementia in the general population.

For more about HIV-related cognitive impairment

Reference: 

Source: 

Topics: 

tags: 

tags development: 

tags problems: 

Pages

Subscribe to RSS - seniors